Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Adamson

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Expert Opinion on Investigational Drugs|November 16, 2019
DNX-2401: an investigational drug for the treatment of recurrent glioblastomaBrandon Philbrick, David C Adamson
Biomedicines|May 5, 2021
Pituitary Adenomas: From Diagnosis to TherapeuticsSamridhi Banskota, David C Adamson
Expert Opinion on Pharmacotherapy|July 5, 2021
Can we rely on synthetic pharmacotherapy for the treatment of glioblastoma?Chibueze D Nwagwu, David C Adamson
Biomedicines|April 3, 2021
Current FDA-Approved Therapies for High-Grade Malignant GliomasJacob P Fisher, David C Adamson
Current Drug Discovery Technologies|February 21, 2012
Stopping cancer in its tracks: using small molecular inhibitors to target glioblastoma migrating cellsAustin K Mattox, Jing Li, David C Adamson
Surgical Neurology|July 21, 2004
Spontaneous cervical epidural hematoma: case report and literature reviewDavid C Adamson, Ketan Bulsara, Peter R Bronec
The Neurologist|April 30, 2005
Upward transtentorial herniation, hydrocephalus, and cerebellar edema in hypertensive encephalopathyDavid C Adamson, Dragan F Dimitrov, Peter R Bronec
Current Drug Discovery Technologies|February 21, 2012
Targeted radiotherapy for malignant gliomasDaniel S Oh, David C Adamson, John P Kirkpatrick
Biomedicines|February 4, 2021
Clinically Explored Virus-Based Therapies for the Treatment of Recurrent High-Grade Glioma in AdultsAmanda V Immidisetti, Chibueze D Nwagwu, David C Adamson, et al.
Pharmaceutics|April 30, 2021
Convection Enhanced Delivery in the Setting of High-Grade GliomasChibueze D Nwagwu, Amanda V Immidisetti, Michael Y Jiang, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Expert Opinion on Investigational Drugs|November 16, 2019
DNX-2401: an investigational drug for the treatment of recurrent glioblastomaBrandon Philbrick, David C Adamson
Biomedicines|May 5, 2021
Pituitary Adenomas: From Diagnosis to TherapeuticsSamridhi Banskota, David C Adamson
Expert Opinion on Pharmacotherapy|July 5, 2021
Can we rely on synthetic pharmacotherapy for the treatment of glioblastoma?Chibueze D Nwagwu, David C Adamson
Biomedicines|April 3, 2021
Current FDA-Approved Therapies for High-Grade Malignant GliomasJacob P Fisher, David C Adamson
Current Drug Discovery Technologies|February 21, 2012
Stopping cancer in its tracks: using small molecular inhibitors to target glioblastoma migrating cellsAustin K Mattox, Jing Li, David C Adamson
Surgical Neurology|July 21, 2004
Spontaneous cervical epidural hematoma: case report and literature reviewDavid C Adamson, Ketan Bulsara, Peter R Bronec
The Neurologist|April 30, 2005
Upward transtentorial herniation, hydrocephalus, and cerebellar edema in hypertensive encephalopathyDavid C Adamson, Dragan F Dimitrov, Peter R Bronec
Current Drug Discovery Technologies|February 21, 2012
Targeted radiotherapy for malignant gliomasDaniel S Oh, David C Adamson, John P Kirkpatrick
Biomedicines|February 4, 2021
Clinically Explored Virus-Based Therapies for the Treatment of Recurrent High-Grade Glioma in AdultsAmanda V Immidisetti, Chibueze D Nwagwu, David C Adamson, et al.
Pharmaceutics|April 30, 2021
Convection Enhanced Delivery in the Setting of High-Grade GliomasChibueze D Nwagwu, Amanda V Immidisetti, Michael Y Jiang, et al.
Pageof 2